Canopy Growth (CGC) FCF Margin Growth (1y) (2020 - 2026)
Canopy Growth (CGC) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | -1,254.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,254.00 |
| Dec 31, 2025 | 1,431.00 |
| Jun 30, 2025 | 6,798.00 |
| Dec 31, 2024 | 451.00 |
| Sep 30, 2024 | 8,540.00 |
| Jun 30, 2024 | 5,772.00 |
| Mar 31, 2024 | -4,824.00 |
| Dec 31, 2023 | 19,108.00 |
| Sep 30, 2023 | -8,035.00 |
| Jun 30, 2023 | -2,150.00 |
| Mar 31, 2023 | 974.00 |
| Dec 31, 2022 | -12,469.00 |
| Sep 30, 2022 | -1,751.00 |
| Jun 30, 2022 | 1,625.00 |
| Mar 31, 2022 | 16,152.00 |
| Dec 31, 2021 | 7,350.00 |
| Sep 30, 2021 | 6,362.00 |
| Jun 30, 2021 | 1,463.00 |
| Mar 31, 2021 | 65,156.00 |
| Dec 31, 2020 | -9,473.00 |